View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Carboplatin 5 / Cyclophosphamide 600, Breast Cancer (tripel-negative)
Protocol-ID: 101 V1.0 (Mini), CRBP5/CYCL600, Breast Ca (tripel-neg.)Indication(s)
- Breast Cancer (tripel negative); ICD-10 C50.-
Links
- Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Bevacizumab as First-line Treatment in Advanced Triple Negative Breast Cancer Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Protocol IDs: M09TNM, 2009-015238-31, NCT01057069 [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 14.10.2016